Actively Recruiting

Phase Not Applicable
Age: 6Months - 65Years
All Genders
NCT07056569

Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD Dermatitis Cream in Adults and Children With Atopic and Contact Dermatitis Symptoms Confirmed by Clinical Parameters

Led by Biokosmes Srl · Updated on 2025-07-09

90

Participants Needed

3

Research Sites

12 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study aims to evaluate and confirm the performance of 047 TD Dermatitis cream in the improvement of eczematous dermatitis and contact dermatitis, throughout a reduction in disease severity and symptoms.

CONDITIONS

Official Title

Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD Dermatitis Cream in Adults and Children With Atopic and Contact Dermatitis Symptoms Confirmed by Clinical Parameters

Who Can Participate

Age: 6Months - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female older than 6 months and younger than 65 years
  • Diagnosed with atopic dermatitis or contact dermatitis
  • Eczema Area and Severity Index (EASI) score less than 16
  • Investigator's Global Assessment (IGA) score between 1 and 3
  • Generally in good health with no serious systemic diseases
Not Eligible

You will not qualify if you...

  • Allergy or hypersensitivity to any ingredient of 047 TD Dermatitis cream
  • Presence of other skin diseases at the treatment area that could affect clinical assessment
  • Use of additional therapies for atopic or contact dermatitis (such as UV therapy, probiotics, homeopathy) within 30 days before study start or during the study
  • Use of other topical treatments or emollients on dermatitis lesions during the study (except usual hygiene products in diaper area)
  • Currently receiving immunosuppressive drugs, chemotherapy, or radiation therapy
  • History of drug abuse
  • Refusal to participate in study procedures or lack of parental consent for minors
  • Inability to provide written informed consent or parental consent for participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Studio Medico Pigatto Bersani

Milan, Italy, 20154

Not Yet Recruiting

2

Poliambulatorio Verona

Verona, Italy, 37135

Actively Recruiting

3

Studio Medico

Voghera, Italy, 27058

Not Yet Recruiting

Loading map...

Research Team

D

Donatella Mariani

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here